An official website of the United States government
Home
Name
Varubi
Alternate Names
Rolapitant
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
None
Primary Site
None
Histology
None
Remarks
September 25, 2015: the FDA approved Varubi to prevent delayed phase chemotherapy-induced nausea and vomiting.
Coding
This drug should NOT be coded
